Acute Myocardial Infarction in Cancer Patients

N/AActive Not RecruitingNCT06281054

Samsung Medical Center4,500,000 enrolled

Overview

Using national health insurance service database, current study aim to evaluate the risk and prognosis of acute myocardial infarction in cancer patients and to find the optimal treatment strategy for acute myocardial infarction that can improve long-term prognosis.

This study will be conducted using Korean National Health Insurance Service database. Patients who were diagnosed with cancer from 2002 to 2021 will be included in the study. Using the selected patients, current study will analyze the incidence and prognosis of acute myocardial infarction in cancer patients and the prognosis according to the treatment method for acute myocardial infarction will be compared. Primary outcome will be all-cause death. Secondary outcomes will be myocardial infarction, revascularization, hospitalization for heart failure, stroke, and clinically relevant bleeding.

Study Type

OBSERVATIONAL

Enrollment

4,500,000

Conditions

Acute Myocardial Infarction Cancer

Interventions

RevascularizationPROCEDURE

Performing PCI or CABG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with cancer between 2002 and 2021 * Patients who were diagnosed with acute myocardial infarction after cancer diagnosis Exclusion Criteria: * Patients who died during period of cancer diagnosis

Locations (1)

Chonnam National University Hospital, Chonnam National University Medical School

Gwangju, South Korea

Outcomes

Primary Outcomes

All-cause death

All-cause death which was obtained from death certification collected by Statistics Korea at the Ministry of Strategy and Finance of South Korea